{"url_path":"/sec/brtx/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1505497/0001493152-26-023126-index.html","accession_number":"0001493152-26-023126","cik":"0001505497","ticker":"BRTX","issuer_name":"BioRestorative Therapies, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1505497/0001493152-26-023126-index.html","primary_entity_key":"0001505497","primary_entity_name":"BioRestorative Therapies, Inc."},"word_count":97,"has_tables":true,"body_markdown":"**Item\n1A. Risk Factors**\n\n \n\nAn\ninvestment in our Common Stock involves a number of very significant risks. You should carefully consider the risk factors included in\nthe “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC\non March 26, 2026, and the other information contained in that report and in this quarterly report in evaluating the Company and its\nbusiness before purchasing shares of our Common Stock. Our business, operating results and financial condition could be adversely affected\ndue to any of those risks."}